DIA

WCCT

WCCT Global launches special population recruitment tool

Tuesday, February 26, 2013 11:01 AM

WCCT Global, a CRO supporting phase I-IV biopharmaceutical and medical device development, has rolled out their special population Recruitment Management Tool (RMT) for early and late phase clinical studies.

More... »

ACRP Certification Program - July 31st

WCCT Global successfully completes enrollment in ethnobridging study

Monday, February 11, 2013 02:37 PM

WCCT Global, a global CRO supporting phase I-IV bio-pharmaceutical and device development, announced the success of their specialized recruitment methods for ethnobridging studies.

More... »

CRF Health – eCOA Forum

WCCT Global, Verified Clinical Trials enhance clinical trials database registry

Monday, January 7, 2013 11:24 AM

WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help them enhance the capabilities of the VCT Clinical Trials Database Registry system.

More... »

Dedicated Phase I Appoints New CMO

Friday, June 26, 2009 10:54 AM

Dedicated Phase I in Phoenix, Ariz., named a new chief medical officer to head its 80-bed phase I clinical research facility. Clark Springgate, M.D., Ph.D., brings more than 25 years' experience to the organization, having directed and participated in more than 256 clinical trials, including first-in-man and first-in-therapeutic-class studies.

More... »

Almac Clinical Services
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

June 17

New CISCRP study finds patient perceptions of trial participation safety, motives greatly improved

PwC: Volume and value of pharma, diagnostics deals soar in first quarter, as CRO sector waits on sidelines

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

Operating environment spurs out-of-the-box ideas
High cost, low success rates drive some sponsors to new monitoring, protocol design, patient-centric initiatives

Private equity interest in CROs could lead to more IPOs
Now flush with cash, many PE investors readying to cash out

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs